Heska Corporation
1825 Sharp Point Drive
Fort Collins
Colorado
80525
United States
Tel: 970-493-7272
Fax: 970-493-7333
Website: http://www.heska.com/
Email: market@heska.com
238 articles about Heska Corporation
-
Heska Corporation Reports First Quarter 2023 Results
5/5/2023
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results for its first quarter ended March 31, 2023.
-
Heska Announces Annual Meeting of Stockholders on May 3, 2023
4/21/2023
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announces its 2023 Annual Meeting of Stockholders.
-
Heska Corporation Reports Fourth Quarter and Full Year 2022 Results
2/28/2023
Heska Corporation reported financial results in two segments for its fourth quarter and full year ended December 31, 2022.
-
Heska to Present at Three Upcoming Institutional Investor Conferences
2/23/2023
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska's management team will present at three institutional investor conferences in March 2023.
-
Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023
2/8/2023
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its fourth quarter and full year 2022 financial performance in a press release before the market opens on Tuesday, February 28, 2023.
-
Heska Corporation Completes Acquisition of LightDeck Diagnostics
1/3/2023
Heska Corporation announced the completion of acquisition of 100% of the shares of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics, a pioneer in planar waveguide fluorescence immunoassay diagnostics with strong manufacturing capabilities and research and development expertise.
-
Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference
12/23/2022
Heska Corporation announced that members of Heska's management team will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
-
Heska Corporation Reports Third Quarter 2022 Results
11/8/2022
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments for its third quarter ended September 30, 2022.
-
Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022
10/18/2022
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its third quarter 2022 financial performance in a press release before the market opens on Tuesday, November 8, 2022.
-
Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development Efforts
9/12/2022
Heska Corporation announced that the Company has entered a definitive agreement to acquire 100% of the share capital of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics, a pioneer in innovative planar waveguide fluorescence immunoassay diagnostics with strong manufacturing and specialized production capabilities.
-
Heska Corporation Reports Second Quarter 2022 Results
8/8/2022
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments ( North America and International) for its second quarter ended June 30, 2022.
-
Heska Second Quarter 2022 Financial Results and Earnings Call Scheduled for August 8, 2022
7/20/2022
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its second quarter 2022 financial performance in a press release before the market opens on Monday, August 8, 2022.
-
Heska to Present at the Upcoming Stifel 2022 Jaws and Paws Conference
5/25/2022
Heska Corporation announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the Stifel 2022 Jaws and Paws Conference at the Pierre New York Hotel in New York City on Wednesday, June 1, 2022 at 3:00 p.m. Eastern Time.
-
Heska Corporation Reports First Quarter 2022 Results
5/9/2022
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments for its first quarter ended March 31, 2022.
-
Heska to Host Virtual 2022 Investor Day on May 17, 2022
4/29/2022
Heska Corporation plans to host its 2022 Investor Day in a virtual format on Tuesday, May 17, 2022 at 9:00 a.m. MT / 11:00 a.m. ET.
-
Heska First Quarter 2022 Financial Results and Earnings Call Scheduled for May 9, 2022
4/18/2022
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its first quarter 2022 financial performance in a press release before the market opens on Monday, May 9, 2022.
-
Heska Announces its Annual Meeting of Stockholders on May 4, 2022
4/14/2022
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announces its 2022 Annual Meeting of Stockholders.
-
Heska Corporation Reports Fourth Quarter and Full Year 2021 Results
2/28/2022
Heska Corporation reported financial results in two segments (North America and International) for its fourth quarter and full year ended December 31, 2021.
-
Heska Fourth Quarter and Full Year 2021 Financial Results and Earnings Call Scheduled for February 28, 2022
1/31/2022
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products and solutions, will report its fourth quarter and full year 2021 financial performance in a press release before the market opens on Monday, February 28, 2022.
-
Heska to Present at the Upcoming Annual J.P. Morgan Health Care Conference
12/28/2021
Heska Corporation announced that Kevin Wilson , Heska's President & Chief Executive Officer, will present at the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday January 11, 2022.